Why is the comparison with Medicare for WESCAPS CAPSULE labelled estimated?

Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Wescaps / B Complex W-C No.20/Folic Acid: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name. Outlier_Flag_2024 is blank in the file. The Part D file leaves the outlier flag for this drug blank. OpenBill counts a blank flag as not flagged, so the figure is used, but CMS has not said whether unusual records distort it.

WESCAPS CAPSULE

For 30 capsules

Pharmacies pay

$3.39 filed

30 × $0.11308 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$16.10 filed

30 × $0.53666 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

The spread

4.7× estimated

Medicare paid 4.7× what pharmacies pay.

Part D averages every strength and form sold under “Wescaps” / “B Complex W-C No.20/Folic Acid” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$8.90 estimated

$3.39 + $0.51 (15%) + $5.00 fee per fill = $8.90

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

WESCAPS CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory does not list its NDC as a package of its own, so OpenBill has no FDA names, dosage form or pharmacologic class for it.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 69367-0314-01.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $3.39 for 30 capsules (30 × $0.11308 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

What NADAC measures · Why 30 capsules · NADAC explanation codes

The NDC

69367-0314-01 · not listed as a package in the FDA directory · $0.11308 per EA · eff. 2026-09-23 filed

What Medicare paid

Medicare Part D paid $16.10 for 30 capsules, at an average of $0.53666 per EA in 2024 (2024-01-01 to 2024-12-31) for “Wescaps” and “B Complex W-C No.20/Folic Acid”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 11 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

What is your cash price for 30 capsules? Is it lower than what I would pay through my insurance?
If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.

Questions

Why is the comparison with Medicare for WESCAPS CAPSULE labelled estimated?: Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Wescaps / B Complex W-C No.20/Folic Acid: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name. Outlier_Flag_2024 is blank in the file. The Part D file leaves the outlier flag for this drug blank. OpenBill counts a blank flag as not flagged, so the figure is used, but CMS has not said whether unusual records distort it.